Science Explorer Interactive view Map
Company · Rheinfelden · Switzerland

Tillotts Pharma (Switzerland)

tillotts.comROR OpenAlex
Research works
31
▲ 122% vs 2013–17
Citations
547
17.4 per fractional work
Top-10% rate
7.5%
record average 16.5%
Open access
73%
world 28%

Not ranked overall: Tillotts Pharma (Switzerland) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 3.68× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 11.55× its world share, 1 worksImmunology and Micro…Pharmacology, Toxicology and Pharmaceutics: 6.58× its world share, 0 worksPharmacology, Toxico…Health Professions: 0.44× its world share, 0 worksHealth ProfessionsMedicine: 3.35× its world share, 5 worksMedicineEconomics, Econometrics and Finance: 0.43× its world share, 0 worksEconomics, Econometr…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 11.6×. Every wedge is a field page.

Which keywords describe research at Tillotts Pharma (Switzerland)?

By fractional works in all years, weighted toward what it does more of than the world: Inflammatory Bowel Disease, Epidemiology, Pathogenesis, Crohn's Disease, Ulcerative Colitis, Proton Pump Inhibitors, Diagnosis and Medication Adherence.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 33 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 33 words, with their numbers
  1. Epidemiology8▲ 6.3×10 topics
  2. Inflammatory Bowel Disease8▲ 238×3 topics
  3. Pathogenesis6▲ 34×3 topics
  4. Crohn's Disease5▲ 198×1 topic
  5. Ulcerative Colitis5▲ 453×1 topic
  6. Diagnosis3▲ 8.7×7 topics
  7. Proton Pump Inhibitors3▲ 108×2 topics
  8. Medication Adherence3▲ 142×2 topics
  9. Collagenous Colitis2▲ 308×1 topic
  10. Microscopic Colitis2▲ 308×1 topic
  11. Clinical Trials2▲ 12×4 topics
  12. Management2▲ 8.8×4 topics
  13. Inflammation2▲ 2.7×6 topics
  14. Off-Label Drug Use2▲ 154×1 topic
  15. Pediatric Pharmacokinetics2▲ 154×1 topic
  16. Prevention2▲ 14×4 topics
  17. Treatment2▲ 3.9×4 topics
  18. Guidelines2▲ 9.9×2 topics
  19. Adrenal Insufficiency1▲ 202×1 topic
  20. Corticosteroid Therapy1▲ 169×1 topic
  21. Intestinal Permeability1▲ 79×2 topics
  22. Antibiotic Resistance1▲ 9.7×2 topics
  23. Risk Factors1▲ 3.7×3 topics
  24. Celiac Disease1▲ 201×1 topic
  25. Chemotherapy1▲ 4.8×2 topics
  26. Gastric Cancer1▲ 27×2 topics
  27. Gluten Sensitivity1▲ 201×1 topic
  28. Prevalence1▲ 8.7×2 topics
  29. Cetuximab1▲ 39×1 topic
  30. Children1▲ 13×2 topics
  31. Eradication Therapy1▲ 65×1 topic
  32. Helicobacter pylori1▲ 65×1 topic
  33. KRAS Mutations1▲ 95×1 topic

Which research topics does Tillotts Pharma (Switzerland) publish most on?

By volume in 2022–2025: Inflammatory Bowel Disease, Microscopic Colitis, Clostridium difficile and Clostridium perfringens research and Celiac Disease Research and Management.

Inflammatory Bowel Disease1Inflammatory Bowel Disease: 1 fractional worksMicroscopic Colitis1Microscopic Colitis: 1 fractional worksClostridium difficile and Clostridium perfringens research: 0 fractional worksCeliac Disease Research and Management: 0 fractional worksImmunodeficiency and Autoimmune Disorders: 0 fractional worksAdrenal Hormones and Dis…0Adrenal Hormones and Disorders: 0 fractional worksWound Healing and Treatments: 0 fractional worksPneumocystis jirovecii pneumonia detection and treatment: 0 fractional worksHelicobacter pylori-related gastroenterology studies: 0 fractional worksAntibiotic Use and Resistance: 0 fractional works
GeneticsEpidemiologyInfectious DiseasesGastroenterology5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Inflammatory Bowel Disease Genetics 1 works
  2. 2 Microscopic Colitis Epidemiology 1 works
  3. 3 Clostridium difficile and Clostridium perfringens research Infectious Diseases 0 works
  4. 4 Celiac Disease Research and Management Gastroenterology 0 works
  5. 5 Immunodeficiency and Autoimmune Disorders Immunology 0 works
  6. 6 Adrenal Hormones and Disorders Endocrinology, Diabetes and Metabolism 0 works
  7. 7 Wound Healing and Treatments Rehabilitation 0 works
  8. 8 Pneumocystis jirovecii pneumonia detection and treatment Epidemiology 0 works
  9. 9 Helicobacter pylori-related gastroenterology studies Surgery 0 works
  10. 10 Antibiotic Use and Resistance Applied Microbiology and Biotechnology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available73.1%not open26.9%

World: 28% of research is openly available.

with international co-authors36.8%domestic only63.2%

World: 19% is written across borders.

How has Tillotts Pharma (Switzerland)'s research output changed?

Output in 2018–2022 was 122% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Rheinfelden

All research institutions in Rheinfelden

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.